Navigation Links
Bright Beginnings(R) NeoCare(TM) Value-Priced Weight Gain Infant Formula Now Available Online at www.pbmstore.com
Date:9/9/2009

GORDONSVILLE, Va., Sept. 9 /PRNewswire/ -- PBM Products, LLC, a leading infant formula company, has introduced Bright Beginnings(R) NeoCare(TM) Weight Gain Infant Formula. Comparable to Similac(R) NeoSure(R), Bright Beginnings(R) NeoCare(TM) is a milk-based infant formula intended to meet the nutritional needs of low birth weight infants (LBW) after hospital discharge.

Clinical evidence suggests that catch-up growth increases when feeding infants nutrient-enriched formulas compared to standard term formulas.* Studies also show that premature infants fed a nutrient-enriched, post-discharge formula such as NeoCare(TM) achieve better growth performance after discharge without tolerance or gastrointestinal issues.

"NeoCare(TM) is our first infant formula designed for premature infants," said V.P. Cynthia M. Barber, Ph.D., who directs regulatory, medical, and clinical affairs at PBM. "This post-discharge formula provides a safe choice in the continued nutritional care of preterm, low birth weight, or small for gestational age [SGA] infants following hospital discharge."

In studies comparing preterm infants fed nutrient-enriched formula with preterm breastfed infants, breastfed infants weighed less and did not experience as great an increase in length as infants fed post-discharge formula. Similarly, SGA infants discharged on a more nutrient-rich formula were significantly longer at 18 months and weighed more at three months of age than infants fed a standard milk-based formula.**

NeoCare(TM) contains a higher level of protein, vitamins, and minerals per 100 Calories than standard term formula (22 Cal/fl oz). NeoCare(TM) also contains:

  • DHA and ARA, which are associated with infant brain and eye development
  • Extra calcium, phosphorous, and zinc to address deficits that may limit linear growth

Bright Beginnings(R) NeoCare(TM) Weight Gain Infant Formula offers a safe and accurate method to provide increased calories and nutrients to the preterm, LBW, and SGA infants. NeoCare(TM) is available in a 12.8 ounce can for $11.99 and is being sold online at www.pbmstore.com/brbenewegain.html.

About PBM

PBM is privately owned and based in Gordonsville, VA. PBM companies specialize in manufacturing, distributing, and marketing consumer food, nutritional, and pharmaceutical products. For more information, visit www.pbmproducts.com.

*Worrell et al. 2002

**Lucas et al. 2001

Similac(R) NeoSure (R) are registered trademarks of Abbott Laboratories.

Breastfeeding is best for babies.

    Contact:  Joe Shields
              Director of Public Relations
              (800) 959-2066 ext. 1131
              jshields@pbmproducts.com


'/>"/>
SOURCE PBM Products, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Discoveries Brighten Search for AIDS Vaccine
2. Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition
3. Mercy Medical Center Selects Bright Horizons to Operate Child Care Center for Employees Children
4. Corbin Bleu Asks Fans to Join Him in Brightening the Lives of Seriously Ill Children
5. Chicago Cosmetic Dentistry Practice Offers Ultra-Thin, Futuristic Lumineers Dental Veneers to Brighten Smiles
6. Green fireworks may brighten eco-friendly 4th of July displays in future
7. Best and Brightest Forum on Medical Innovation Brings Senator Arlen Specter, U.S. Representative Anna Eshoo, and Innovation Leaders Together in Washington, D.C., This Week
8. Council for American Medical Innovation and The Aspen Institute Bring Leaders Together In Washington, D.C., To Discuss The Economic Impact Of Medical Science and Discovery, and Policies Needed To Maintain U.S. Leadership at Best And Brightest Forum On Me
9. A Bright Spot - Financial Help for Seniors
10. Employers Make New Commitments to Back-Up Child and Elder Care Solutions with Bright Horizons
11. Colgate Bright Smiles, Bright Futures(R) Kids Initiative Visits Los Angeles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: